REGN
Regeneron Pharmaceuticals Inc.
$561.63
-$3.00(-0.53%)
56
Overall
80
Value
45
Tech
44
Quality
Market Cap
$62.74B
Volume
1.04M
52W Range
$476.49 - $1,024.36
Target Price
$729.85
EPS Estimates Overview
| Current Quarter | $7.8 | Next Quarter | $7.43 |
| Current Year | $32.36 | Next Year | $31.57 |
| QoQ Growth | -4.7% | YoY Growth | -2.4% |
| 3Y EPS CAGR | -18.8% | Target Price | $729.85 |
| Consensus | Buy | Upside | +30.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $561.63 | -0.5% | 1.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW